Patients with moderate-to-severe atopic dermatitis maintain stable response with no or minimal fluctuations with 1 year of lebrikizumab treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Dermatology and Therapy, 14, 8, S. 2249-2260
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2024
- Ereignis
-
Veröffentlichung
- (wer)
-
Springer Science and Business Media LLC
- (wann)
-
2024
- Urheber
-
Silverberg, Jonathan I.
Wollenberg, Andreas
Stein Gold, Linda
Del Rosso, James
Yosipovitch, Gil
Lio, Peter
Carrascosa, Jose-Manuel
Gallo, Gaia
Ding, Yuxin
Xu, Zhenhui
Casillas, Marta
Pierce, Evangeline
Agell, Helena
Ständer, Sonja
- DOI
-
10.1007/s13555-024-01226-9
- URN
-
urn:nbn:de:bvb:384-opus4-1155456
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Silverberg, Jonathan I.
- Wollenberg, Andreas
- Stein Gold, Linda
- Del Rosso, James
- Yosipovitch, Gil
- Lio, Peter
- Carrascosa, Jose-Manuel
- Gallo, Gaia
- Ding, Yuxin
- Xu, Zhenhui
- Casillas, Marta
- Pierce, Evangeline
- Agell, Helena
- Ständer, Sonja
- Universität Augsburg
- Springer Science and Business Media LLC
Entstanden
- 2024
Ähnliche Objekte (12)
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis
Efficacy of docosahexaenoic acid in patients with atopic dermatitis
Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies
Aggregate response benefit in skin clearance and itch reduction with upadacitinib or dupilumab in patients with moderate-to-severe atopic dermatitis
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
Brain Processing of Contagious Itch in Patients with Atopic Dermatitis
Patient-reported burden in adults with atopic dermatitis: an international qualitative study
More time spent with clear skin and no itch with upadacitinib versus dupilumab for atopic dermatitis
Study of the efficacy of a new topical skin formulation rich in antioxidants in patients with mild to moderate atopic dermatitis
Atopic dermatitis: factors associated with age of onset in adulthood versus childhood [Abstract]
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis
Efficacy of docosahexaenoic acid in patients with atopic dermatitis
Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies
Aggregate response benefit in skin clearance and itch reduction with upadacitinib or dupilumab in patients with moderate-to-severe atopic dermatitis
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
Brain Processing of Contagious Itch in Patients with Atopic Dermatitis
Patient-reported burden in adults with atopic dermatitis: an international qualitative study
More time spent with clear skin and no itch with upadacitinib versus dupilumab for atopic dermatitis
Study of the efficacy of a new topical skin formulation rich in antioxidants in patients with mild to moderate atopic dermatitis
Atopic dermatitis: factors associated with age of onset in adulthood versus childhood [Abstract]
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis
Efficacy of docosahexaenoic acid in patients with atopic dermatitis
Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies
Aggregate response benefit in skin clearance and itch reduction with upadacitinib or dupilumab in patients with moderate-to-severe atopic dermatitis
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
Brain Processing of Contagious Itch in Patients with Atopic Dermatitis
Patient-reported burden in adults with atopic dermatitis: an international qualitative study
More time spent with clear skin and no itch with upadacitinib versus dupilumab for atopic dermatitis
Study of the efficacy of a new topical skin formulation rich in antioxidants in patients with mild to moderate atopic dermatitis
Atopic dermatitis: factors associated with age of onset in adulthood versus childhood [Abstract]